Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-13-030378

Options or other derivatives

  • Director acquired 273,256 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Waksal Harlan · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-05-17 Grant or award : show line 1 in the form Common Stock Option +273,256 $0.04 2023-05-17 273,256 2,716,572 D
Loading xslF345X03/form459801_20130520115056-.xml…